Medcura
Latest round
- Seed
Last raised
- Jul 2020
Total raised
- Undisclosed
Investors
- 3
About Medcura
Founded in 2013 and based in Maryland, US, Medcura Inc. is a medical device company that develops hemostatic and wound treatment products. In March 2024, Medcura Inc. Medcura specializes in advanced hemostatic solutions using biopolymer technologies to manage surgical bleeding. Its flagship product, LifeGel™, controls bleeding effectively without the swelling issues common in existing agents. Utilizing hydrophobically modified chitosan, Medcura's technology creates a mechanical barrier through mucoadhesion, improving bleeding management and reducing costs across various procedures, including spine, cardiac, and minimally invasive surgeries. The company’s portfolio features a range of products, including bandages, foams, putties, surgical gels, and powders.
Who invested in Medcura
3 investors across 2 rounds
See all investors in Medcura
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Medcura
Who invested in Medcura?
Medcura has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Medcura raised?
Medcura has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Medcura last raise money?
Medcura's most recent round on record is a Seed, in Jul 2020.
What does Medcura do?
Founded in 2013 and based in Maryland, US, Medcura Inc.
Where is Medcura headquartered?
Medcura is headquartered in US.
Which VCs invest in companies like Medcura?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Medcura's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like Medcura? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.